February 2, 2016 : DCMS #278

DISASTERS AVERTED — Near Miss Case Studies

Meet the Patient Where They Are

HOMERUN SLIDES — Great Clinical Presentation Highlights

Diabetes for Cardiologists Part 8

CLINICAL GEMS — The Best from Diabetes Texts

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #9: Epidemiology and Risk Factors for Type 1 Diabetes Mellitus Part 3 of 5

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

• Part 1: Dr. Aaron Vinik Discusses the Shift in Diabetes Care (transcript)
• Part 2: Dr. Aaron Vinik Discusses INGAP Research (transcript)

MOST POPULAR ARTICLES OF THE MONTH

#1 A New Proposed Classification of Diabetes: No More Type 1 or Type 2 Diabetes
#2 Antioxidants May Help Reduce Diabetes Risk
#3 Liraglutide Success Shown Dependent on Early Weight Loss

It appears that we are now looking more and more at diabetes as a cardiovascular risk factor, and our therapies and goals for diabetes care need to be targeted in that direction. In order to help make this message as clear as possible, we have focused our homerun slides and our exclusive interview on this concept.

Our Diabetes for Cardiologists slides look at the use of Sulfonylureas in heart patients and the cardiovascular risks associated, while our Exclusive Interview has our publisher, Steve Freed, in discussion with Dr. Aaron Vinik about this new concept of “treating for cardiovascular outcomes.”

As a special bonus Dr. Vinik discusses how current INGAP research may change how we treat diabetes patients for many years to come.

Your partner in diabetes care,
Dave Joffe
Editor-in-chief

A 15-year-old type 1 diabetic is seen who frequently forgets to take her insulin because of time issues. At the time of her initial appointment, her A1C was 10.4. After discussing issues preventing her from taking her insulin, I suggested that she take her insulin through her clothes.

In this week’s Homerun Slides, the cardiovascular risk of using sulfonylureas.

The first large-scale studies of the prediction of T1DM relied upon the detection of cytoplasmic islet cell autoantibodies (ICA) assays based on indirect immunofluorescence. High titer cytoplasmic ICA is most often associated with the presence of multiple islet autoantibodies and therefore a high risk of progression to diabetes.

In part 1 of this exclusive interview, DIC publisher Steve Freed talks with Dr. Aaron Vinik about the shift away from rigorous glycemic control in favor of greater focus on the impact of diabetes treatment on the heart.

In part 2 of this exclusive interview, Dr. Aaron Vinik shares an update on INGAP research.

β-cell centric classification of diabetes puts focus on single common denominator of all types.

Study shows high carotenoid serum concentration may prevent development of type 2.

Patients who responded to medication had greater improvement in cardiometabolic risk factors.